During yesterday and today, the stock has gone from a high of $1.97 to a low of $1.76 and is now trading at $1.83.
Also see my original story "Pfizer whistleblower accuses company of using sales force to illegally market new AIDS-drug before FDA approval"

Monogram Bioscience now trades about 6% below the price before the disclosures were made on this blog and 16% below the price 5 days ago.

No comments:
Post a Comment